Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11520 posts found.

Tarceva/Avastin combination disappoints in kidney cancer

October 19, 2005 Sales and Marketing

Early results from trials suggest adding Tarceva to Avastin has no extra benefit in the treatment of kidney cancer.Researchers at …
News

Exubera recommended by European regulator

October 18, 2005 Sales and Marketing

Exubera, the first ever inhaled insulin product is set for approval in Europe following a key regulatory recommendation.The positive opinion …
News

Pfizer wins UK Lipitor court battle

October 14, 2005 Sales and Marketing

Pfizer has won an important legal battle to maintain its UK patent on best-selling cholesterol drug Lipitor.The UK High Court …
News

Sanofi-Aventis launch new short-acting insulin competitor Apidra

October 13, 2005 Sales and Marketing

Apidra, a new short-acting insulin analogue, has been launched in the UK by Sanofi-Aventis.Short-acting analogues have a faster onset of …
News

EMEA reforms to speed drug approval

October 13, 2005 Sales and Marketing

Europe's medicines regulator is looking to communicate more effectively with pharma companies as part of a drive to accelerate drug …
News

Merck looks to rebuild reputation one year on from Vioxx

October 13, 2005 Sales and Marketing

Merck looks set to launch a new public relations campaign across Europe in an attempt to repair damage done to …
News

VNU shareholders rebel over IMS bid

October 13, 2005 Sales and Marketing

A significant minority of shareholders in VNU are against its planned $7 billion acquisition of pharmaceutical information company IMS Health.The …
News

Reducing POM to P headaches

October 12, 2005 Sales and Marketing

Following an eight-week period of public consultation, the Committee on Safety of Medicines is to shortly advise health ministers about …
Feature

Pharma cast as ‘bad guys’ in Hollywood blockbuster

September 30, 2005 Sales and Marketing

A new Hollywood thriller featuring the pharmaceutical industry as the 'bad guys' is to hit UK screens next week.The Constant …
News

Davis to leave Takeda UK

September 30, 2005 Sales and Marketing

Andy Davis, the high-profile managing director of Takeda UK is to leave the company.Davis is best known for overseeing a …
News

New leader for FDA in turmoil

September 30, 2005 Sales and Marketing

Andrew von Eschenbach has been appointed the new acting head of the FDA after the surprise resignation of Lester Crawford.Crawford …
News

NICE seeks urgent fix for slow appraisals

September 29, 2005 Sales and Marketing

Patients waiting for access to new, more effective medicines could be prescribed them earlier if new proposals are adopted.NICE, the …
News

Astellas launches Flomaxtra XL

September 27, 2005 Sales and Marketing

Astellas has launched Flomaxtra XL, a new treatment for the symptoms of BPH or benign prostatic hyperplasia.The condition is the …
News

US rejects Pfizer’s injectable Cox-II

September 22, 2005 Sales and Marketing

The FDA has denied approval for Pfizer's injectable pain drug Dynastat, delivering a fresh blow to the embattled Cox-II class …
News

Roche’s Tarceva approved in Europe

September 21, 2005 Sales and Marketing

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025